Gilead Sciences (GILD), Galapagos NV (GLPG) Report Efficacy & Safety Results of Filgotinib Through 52 Weeks in FINCH 1 and FINCH 3 Studies in Rheumatoid Arthritis

October 11, 2019 6:04 AM
Gilead Sciences, Inc. (NASDAQ: GILD) and Galapagos NV (NASDAQ: GLPG) today announced that Week 52 data from the registrational Phase ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles